We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.46%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$81.2B
AUM Growth
+$4.94B
(+6.5%)
Cap. Flow
-$6.14B
Cap. Flow
% of AUM
-7.55%
Top 10 Holdings %
Top 10 Hldgs %
23.23%
Holding
2,627
New
307
Increased
786
Reduced
648
Closed
292
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$410M |
| 2 |
American Electric Power
AEP
|
+$309M |
| 3 |
UnitedHealth
UNH
|
+$239M |
| 4 |
Johnson & Johnson
JNJ
|
+$235M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$330M |
| 2 |
Consolidated Edison
ED
|
+$330M |
| 3 |
PNC Financial Services
PNC
|
+$284M |
| 4 |
Salesforce
CRM
|
+$173M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.56% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 13.3% |
| 4 | Industrials | 12.02% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Ultragenyx Pharmaceutical
RARE
$2.54B
| $73K | ﹤0.01% |
1,590
-1,320
| -45% | -$61.2K |
|
1477
Simulations Plus
SLP
$371M
| $73K | ﹤0.01% |
1,694
| – | – |
|
1478
Dime Commercial Bancshares
DCOM
$1.84B
| $72K | ﹤0.01% |
4,155
+3,111
| +298% | +$57.9K |
|
|
PPLI
1479
People Inc
PPLI
$3.45B
| $72K | ﹤0.01% |
1,401
+585
| +72% | +$26.8K |
|
|
MGIC
1480
DELISTED
Magic Software Enterprises
MGIC
| $72K | ﹤0.01% |
5,480
+1,839
| +51% | +$24.4K |
|
1481
Napco Security Technologies
NSSC
$1.44B
| $72K | ﹤0.01% |
+2,091
| New | +$73K |
|
1482
Wendy's
WEN
$1.46B
| $72K | ﹤0.01% |
+3,317
| New | +$73.9K |
|
|
SGI
1483
Somnigroup International
SGI
$14.7B
| $72K | ﹤0.01% |
+1,811
| New | +$68.1K |
|
|
BBT
1484
Beacon Financial Corp
BBT
$2.71B
| $71K | ﹤0.01% |
3,425
+1,798
| +111% | +$38.8K |
|
|
FOLD
1485
DELISTED
Amicus Therapeutics
FOLD
| $71K | ﹤0.01% |
5,700
-9,680
| -63% | -$115K |
|
|
FSP
1486
Franklin Street Properties
FSP
$48.4M
| $71K | ﹤0.01% |
49,118
+584
| +1% | +$808 |
|
1487
Sonos
SONO
$1.94B
| $71K | ﹤0.01% |
4,385
-3,226
| -42% | -$57.2K |
|
1488
TORM
TRMD
$3.01B
| $71K | ﹤0.01% |
2,948
| – | – |
|
1489
World Acceptance Corp
WRLD
$902M
| $71K | ﹤0.01% |
+532
| New | +$57.2K |
|
1490
Woodward
WWD
$22.1B
| $71K | ﹤0.01% |
+602
| New | +$63.8K |
|
|
SMMF
1491
DELISTED
Summit Financial Group, Inc.
SMMF
| $71K | ﹤0.01% |
3,467
+33
| +1% | +$649 |
|
1492
argenx
ARGX
$52.8B
| $70K | ﹤0.01% |
180
| – | – |
|
1493
Bioceres Crop Solutions
BIOX
$24.1M
| $70K | ﹤0.01% |
+5,241
| New | +$61.5K |
|
1494
Pathward Financial
CASH
$1.89B
| $70K | ﹤0.01% |
+1,523
| New | +$68.3K |
|
1495
Ironwood Pharmaceuticals
IRWD
$709M
| $70K | ﹤0.01% |
6,612
+6,503
| +5,966% | +$69.9K |
|
1496
RxSight
RXST
$259M
| $70K | ﹤0.01% |
+2,447
| New | +$54.4K |
|
1497
SI-BONE Inc
SIBN
$818M
| $70K | ﹤0.01% |
+2,630
| New | +$64.1K |
|
|
BPMC
1498
DELISTED
Blueprint Medicines
BPMC
| $69K | ﹤0.01% |
+1,103
| New | +$60K |
|
1499
Select Water Solutions
WTTR
$2.3B
| $69K | ﹤0.01% |
8,560
| – | – |
|
1500
American Homes 4 Rent
AMH
$12.4B
| $68K | ﹤0.01% |
1,936
-8,225
| -81% | -$279K |
|
Similar funds
QCM
Lazard Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Lazard Asset Management held 2,627 positions worth $81.2B, up 6.5% from $76.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $6.14B in Q2 2023, closing 292 positions and reducing 648 holdings. Its most notable exit was ABB Ltd, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Nice worth $14.7M.
- Lazard Asset Management's largest Q2 2023 buy was Nice: 71,266 shares worth $14.7M.
- Lazard Asset Management added most to Exelon in Q2 2023, an estimated $410M increase.
- Lazard Asset Management's biggest Q2 2023 reduction was Dollar General, cutting an estimated $330M.
- Lazard Asset Management fully exited ABB Ltd in Q2 2023, selling an estimated $107M.
- Lazard Asset Management's ten largest holdings make up 23% of its $81.2B portfolio in Q2 2023.
- Lazard Asset Management opened 307 new positions and closed 292 in Q2 2023.
- Lazard Asset Management's portfolio value rose 6.5% quarter-over-quarter to $81.2B.
Based on Lazard Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.